Congratulations to Mammoth Biosciences for signing a $691M collaboration deal with Vertex→

Vertex Pharmaceuticals and Mammoth Biosciences today announced a new partnership to develop in vivo gene-editing therapies for two genetic diseases using Mammoth’s next-generation CRISPR systems.

Read More —>